INFLUENCE OF ALPHA-CYCLODEXTRIN AND HYDROXYALKYLATED BETA-CYCLODEXTRIN DERIVATIVES ON THE IN-VITRO CORNEAL UPTAKE AND PERMEATION OF AQUEOUSPILOCARPINE-HCL SOLUTIONS
B. Siefert et S. Keipert, INFLUENCE OF ALPHA-CYCLODEXTRIN AND HYDROXYALKYLATED BETA-CYCLODEXTRIN DERIVATIVES ON THE IN-VITRO CORNEAL UPTAKE AND PERMEATION OF AQUEOUSPILOCARPINE-HCL SOLUTIONS, Journal of pharmaceutical sciences, 86(6), 1997, pp. 716-720
Interactions in aqueous solution between pilocarpine hydrochloride (P-
HCl), a rather hydrophilic drug with good water solubility, and variou
s cyclodextrins (CDs) were described recently. To assess the influence
of CDs on the diffusion behavior of pilocarpine, in vitro studies wer
e performed using porcine or bovine corneas as diffusion barriers. The
affinity of P-HCl for porcine cornea in the presence of alpha-cyclode
xtrin (alpha-CD) and (hydroxyethyl)-beta-cyclodextrin (HE-beta-CD) was
determined by drug uptake experiments. Additionally, in vitro permeat
ion experiments through bovine corneas were conducted with a modified
diffusion device optimized for corneal perfusion studies. The results
obtained from the corneal uptake studies indicate that the addition of
alpha-CD led to increased tissue drug levels. The increase in permeab
ility of pilocarpine in the presence of alpha-CD was similar to 10-fol
d (log P-app = -4.87 +/- 0.03) in comparison with plain P-HCl solution
(log P-app = -5.89 +/- 0.06). Permeation studies with corneas pretrea
ted with alpha-CD solution revealed enhanced corneal permeability of p
ilocarpine due to alpha-CD-induced membrane effects. The hydroxyalkyla
ted beta-CD derivatives HE-beta-CD (log P-app = -6.27 +/- 0.09) and (h
ydroxypropyl)-beta-cyclodextrin (HP-beta-CD; log P-app = -6.40 +/- 0.0
3), however, seemed to cause slightly decreased permeation rates, supp
orting the concept of an interaction between pilocarpine and the hydro
xyalkylated-beta-CD derivatives. Considering physiological compatibili
ty, the addition of CDs seems to be an effective tool to modify and op
timize the ocular availability of pilocarpine.